CanSino OTC Pink Sheet Buy Hold or Sell Recommendation

CASBF
 Stock
  

USD 13.26  0.37  2.71%   

Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding CanSino Biologics is 'Strong Sell'. Macroaxis provides CanSino Biologics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CASBF positions. The advice algorithm takes into account all of CanSino Biologics' available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from CanSino Biologics' buy-and-hold perspective. Continue to CanSino Biologics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as CanSino and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards CanSino Biologics.

Execute CanSino Biologics Buy or Sell Advice

The CanSino recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on CanSino Biologics. Macroaxis does not own or have any residual interests in CanSino Biologics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute CanSino Biologics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell CanSino BiologicsBuy CanSino Biologics
Strong Sell

Volatility

Details

Hype Condition

Details

Current Valuation

Details

Odds of Distress

Details

Economic Sensitivity

Details

Analyst Consensus

Not Available
Details

Reporting Quality (M-Score)

Details
For the selected time horizon CanSino Biologics has a Mean Deviation of 3.99, Semi Deviation of 2.99, Standard Deviation of 7.21, Variance of 51.92, Downside Variance of 41.61 and Semi Variance of 8.91
Our trade advice tool can cross-verify current analyst consensus on CanSino Biologics and to analyze the company potential to grow in the current economic cycle. To make sure CanSino Biologics is not overpriced, please confirm all CanSino Biologics fundamentals, including its net income, book value per share, and the relationship between the revenue and total debt . Given that CanSino Biologics has a shares owned by institutions of 38.80 %, we suggest you to validate CanSino Biologics market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

CanSino Biologics Trading Alerts and Improvement Suggestions

CanSino Biologics is way too risky over 90 days horizon
CanSino Biologics appears to be risky and price may revert if volatility continues
About 27.0% of the company shares are held by company insiders

CanSino Biologics Returns Distribution Density

The distribution of CanSino Biologics' historical returns is an attempt to chart the uncertainty of CanSino Biologics' future price movements. The chart of the probability distribution of CanSino Biologics stock daily returns describes the distribution of returns around its average expected value. We use CanSino Biologics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of CanSino Biologics returns is essential to provide solid investment advice for CanSino Biologics.
Mean Return1.28Value At Risk-6.71
Potential Upside18.99Standard Deviation7.21
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of CanSino Biologics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

CanSino Biologics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to CanSino Biologics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that CanSino Biologics' price will be affected by overall otc pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a CanSino otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
1.31
β
Beta against NYSE Composite-0.4
σ
Overall volatility
7.33
Ir
Information ratio 0.16

CanSino Biologics Volatility Alert

CanSino Biologics is displaying above-average volatility over the selected time horizon. Investors should scrutinize CanSino Biologics independently to ensure intended market timing strategies are aligned with expectations about CanSino Biologics volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure CanSino Biologics' otc pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact CanSino Biologics' otc pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

CanSino Biologics Fundamentals Vs Peers

Comparing CanSino Biologics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze CanSino Biologics' direct or indirect competition across all of the common fundamentals between CanSino Biologics and the related equities. This way, we can detect undervalued stocks with similar characteristics as CanSino Biologics or determine the otc pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of CanSino Biologics' fundamental indicators could also be used in its relative valuation, which is a method of valuing CanSino Biologics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare CanSino Biologics to competition
FundamentalsCanSino BiologicsPeer Average
Return On Equity0.0111 %(0.31) %
Return On Asset(0.0207) %(0.14) %
Profit Margin0.06 %(1.27) %
Operating Margin(0.19) %(5.51) %
Current Valuation4.27 B16.62 B
Shares Outstanding114.78 M571.82 M
Shares Owned by Insiders26.73 %10.09 %
Shares Owned by Institutions38.80 %39.21 %
Price to Earning19.25 X28.72 X
Price to Book3.12 X9.51 X
Price to Sales2.70 X11.42 X
Revenue4.3 B9.43 B
Gross Profit3 B27.38 B
EBITDA2.05 B3.9 B
Net Income1.91 B570.98 M
Cash and Equivalents7 B2.7 B
Cash per Share28.36 X5.01 X
Total Debt40 M5.32 B
Debt to Equity0.26 %48.70 %
Current Ratio2.99 X2.16 X
Book Value Per Share29.22 X1.93 K
Cash Flow from Operations2.05 B971.22 M
Earnings Per Share0.55 X3.12 X
Number of Employees1.95 K18.84 K
Beta0.45-0.15
Market Capitalization5.19 B19.03 B
Total Asset11.87 B29.47 B
Z Score1.28.72
Annual Yield0.0088 %
Net Asset11.87 B
Last Dividend Paid0.8

About CanSino Biologics Buy or Sell Advice

When is the right time to buy or sell CanSino Biologics? Buying financial instruments such as CanSino OTC Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having CanSino Biologics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Data Storage Thematic Idea Now

Data Storage
Data Storage Theme
Companies making data storages or providing data storage services. The Data Storage theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Data Storage Theme or any other thematic opportunities.
View All  Next Launch
Continue to CanSino Biologics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the CanSino Biologics information on this page should be used as a complementary analysis to other CanSino Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for CanSino OTC Pink Sheet analysis

When running CanSino Biologics price analysis, check to measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Please note, there is a significant difference between CanSino Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine CanSino Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CanSino Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.